These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15114369)

  • 1. Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency.
    Andersen PS; Havndrup O; Bundgaard H; Larsen LA; Vuust J; Pedersen AK; Kjeldsen K; Christiansen M
    Eur J Hum Genet; 2004 Aug; 12(8):673-7. PubMed ID: 15114369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
    Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
    Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region.
    Hougs L; Havndrup O; Bundgaard H; Køber L; Vuust J; Larsen LA; Christiansen M; Andersen PS
    Eur J Hum Genet; 2005 Feb; 13(2):161-5. PubMed ID: 15483641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.
    Rottbauer W; Gautel M; Zehelein J; Labeit S; Franz WM; Fischer C; Vollrath B; Mall G; Dietz R; Kübler W; Katus HA
    J Clin Invest; 1997 Jul; 100(2):475-82. PubMed ID: 9218526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A frame shift mutation, Arg346fs mutation, is identified in cardiac myosin-binding protein C gene in a Chinese family with hypertrophic cardiomyopathy].
    Xie WL; Liu WL; Hu DY; Cui W; Zhu TG; Li CL; Sun YH; Li L; Bian H
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):963-6. PubMed ID: 16061003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect.
    García-Castro M; Reguero JR; Alvarez V; Batalla A; Soto MI; Albaladejo V; Coto E
    Int J Cardiol; 2005 Jul; 102(3):501-7. PubMed ID: 16004897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3.
    Oliva-Sandoval MJ; Ruiz-Espejo F; Monserrat L; Hermida-Prieto M; Sabater M; García-Molina E; Ortiz M; Rodríguez-García MI; Núñez L; Gimeno JR; Castro-Beiras A; Valdés M
    Heart; 2010 Dec; 96(24):1980-4. PubMed ID: 21088121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
    Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel mutations in exon 21 encoding beta-cardiac myosin heavy chain.
    Moric E; Mazurek U; Połońska J; Domal-Kwiatkowska D; Smolik S; Kozakiewicz K; Tendera M; Wilczok T
    J Appl Genet; 2003; 44(1):103-9. PubMed ID: 12590187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy.
    Meurs KM; Sanchez X; David RM; Bowles NE; Towbin JA; Reiser PJ; Kittleson JA; Munro MJ; Dryburgh K; Macdonald KA; Kittleson MD
    Hum Mol Genet; 2005 Dec; 14(23):3587-93. PubMed ID: 16236761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Family hypertrophic cardiomyopathy caused by a 14035c > t mutation in cardiac troponin T gene].
    Wang SX; Zou YB; Fu CY; Song L; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):371-4. PubMed ID: 17456375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.